CN/EN
Aims to be a Global Leader in Cell Therapy

Founded in August 2009, Innovative Cellular Therapeutics (ICTTM) is positioned to become a global leader in cell therapy and committed to improving human health through vigorous scientific & technological innovation.

 

 

In the field of cell therapy, stem cells and gene editing, ICTTM has reached international advanced level and has acquired more than 30 Chinese and international patents. The company is now recognized as one of the leading players in CAR-T cell therapy.

 

ICTTM provides pharmaceutical research and development in the pharmaceutical and biotechnology fields.